Previous close | 58.24 |
Open | 59.70 |
Bid | 57.36 x 100 |
Ask | 57.61 x 200 |
Day's range | 57.39 - 60.36 |
52-week range | 27.02 - 73.00 |
Volume | |
Avg. volume | 347,227 |
Market cap | 2.078B |
Beta (5Y monthly) | 1.32 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Key Insights Keros Therapeutics' estimated fair value is US$93.42 based on 2 Stage Free Cash Flow to Equity Current...
Despite Higher Losses, KROS Advances Clinical Trials and Strengthens Cash Position
Keros Therapeutics, Inc. (KROS) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.